COVID-19 infection prevention and control management during
hyperbaric oxygen therapy: a best practice implementation
project

J 2023

COVID-19 infection prevention and control management during hyperbaric oxygen therapy: a best practice implementation project

HAJEK, Michal, Dittmar CHMELAR, Miroslav ROZLOZNIK, Alexandra LOCHMANOVA, Jakub TLAPAK et. al.

Základní údaje

Originální název

COVID-19 infection prevention and control management during hyperbaric oxygen therapy: a best practice implementation project

Autoři

HAJEK, Michal (203 Česká republika), Dittmar CHMELAR (203 Česká republika), Miroslav ROZLOZNIK (203 Česká republika), Alexandra LOCHMANOVA (203 Česká republika), Jakub TLAPAK (203 Česká republika), Tereza VRBOVÁ (203 Česká republika, domácí), Miloslav KLUGAR (203 Česká republika, domácí) a Jitka KLUGAROVÁ (203 Česká republika, domácí)

Vydání

JBI EVIDENCE IMPLEMENTATION, PHILADELPHIA, LIPPINCOTT WILLIAMS & WILKINS, 2023, 2691-3321

Další údaje

Jazyk

angličtina

Typ výsledku

Článek v odborném periodiku

Obor

30230 Other clinical medicine subjects

Stát vydavatele

Spojené státy

Utajení

není předmětem státního či obchodního tajemství

Odkazy

URL

Impakt faktor

Impact factor: 2.300 v roce 2022

Kód RIV

RIV/00216224:14110/23:00133702

Organizační jednotka

Lékařská fakulta

DOI

http://dx.doi.org/10.1097/XEB.0000000000000400

UT WoS

001111566500002

Klíčová slova anglicky

COVID-19; health care professionals; hyperbaric oxygen therapy; infection control

Štítky

14119612, 14119613, rivok

Příznaky

Mezinárodní význam, Recenzováno

Změněno: 29. 2. 2024 14:57, Mgr. Tereza Miškechová

Anotace

V originále

Objective:This implementation project compared standard operating procedures, accepted preventive measures, and disinfection procedures between the initial stage of the COVID-19 pandemic (first wave: March 15 to May 31, 2020) and the later stages of the pandemic (second and third waves: September 1, 2020 to January 31, 2021).Introduction:This project sought to improve compliance with international evidence-based guidelines and clinical standards for the prevention and control of COVID-19 infection during hyperbaric oxygen therapy taking into account the conditions of the local hospital.Methods:Guided by the JBI evidence implementation framework, seven evidence-based audit criteria were developed for the prevention and control of COVID-19 infection during hyperbaric oxygen therapy. A questionnaire was used to measure compliance in baseline and follow-up audits.Results:Differences between the baseline and follow-up audits were noted for criteria 6 and 7. Criterion 6 increased from 0% to 100% as the hyperbaric facility was equipped with certified ultraviolet-C radiation for air disinfection during the later period, but this equipment was not available in the initial period of the pandemic. Criterion 7 dropped from 100% in the baseline audit to 0% in the follow-up audit because of a significant increase in the operational burden of the treatment capacity of the facility, which made it impossible to comply with the recommended distancing between patients.Conclusions:Differences were found in preventive measures, disinfection procedures, work organization, and approach to care strategy. The project objectives were met and the implementation strategies proved effective. Larger sample sizes would need be needed to confirm the reproducibility of the results.

Citovat

HAJEK, Michal, Dittmar CHMELAR, Miroslav ROZLOZNIK, Alexandra LOCHMANOVA, Jakub TLAPAK, Tereza VRBOVÁ, Miloslav KLUGAR a Jitka KLUGAROVÁ. COVID-19 infection prevention and control management during hyperbaric oxygen therapy: a best practice implementation project. JBI EVIDENCE IMPLEMENTATION. PHILADELPHIA: LIPPINCOTT WILLIAMS & WILKINS, 2023, roč. 21, S1, s. "S57"-"S63", 7 s. ISSN 2691-3321. Dostupné z: https://dx.doi.org/10.1097/XEB.0000000000000400.

@article{2379981,
   author = {Hajek, Michal and Chmelar, Dittmar and Rozloznik, Miroslav and Lochmanova, Alexandra and Tlapak, Jakub and Vrbová, Tereza and Klugar, Miloslav and Klugarová, Jitka},
   article_location = {PHILADELPHIA},
   article_number = {S1},
   doi = {http://dx.doi.org/10.1097/XEB.0000000000000400},
   keywords = {COVID-19; health care professionals; hyperbaric oxygen therapy; infection control},
   language = {eng},
   issn = {2691-3321},
   journal = {JBI EVIDENCE IMPLEMENTATION},
   title = {COVID-19 infection prevention and control management during hyperbaric oxygen therapy: a best practice implementation project},
   url = {https://journals.lww.com/ijebh/fulltext/2023/12001/covid_19_infection_prevention_and_control.7.aspx},
   volume = {21},
   year = {2023}
}

TY  - JOUR
ID  - 2379981
AU  - Hajek, Michal - Chmelar, Dittmar - Rozloznik, Miroslav - Lochmanova, Alexandra - Tlapak, Jakub - Vrbová, Tereza - Klugar, Miloslav - Klugarová, Jitka
PY  - 2023
TI  - COVID-19 infection prevention and control management during hyperbaric oxygen therapy: a best practice implementation project
JF  - JBI EVIDENCE IMPLEMENTATION
VL  - 21
IS  - S1
SP  - "S57"-"S63"
EP  - "S57"-"S63"
PB  - LIPPINCOTT WILLIAMS & WILKINS
SN  - 26913321
KW  - COVID-19
KW  - health care professionals
KW  - hyperbaric oxygen therapy
KW  - infection control
UR  - https://journals.lww.com/ijebh/fulltext/2023/12001/covid_19_infection_prevention_and_control.7.aspx
N2  - Objective:This implementation project compared standard operating procedures, accepted preventive measures, and disinfection procedures between the initial stage of the COVID-19 pandemic (first wave: March 15 to May 31, 2020) and the later stages of the pandemic (second and third waves: September 1, 2020 to January 31, 2021).Introduction:This project sought to improve compliance with international evidence-based guidelines and clinical standards for the prevention and control of COVID-19 infection during hyperbaric oxygen therapy taking into account the conditions of the local hospital.Methods:Guided by the JBI evidence implementation framework, seven evidence-based audit criteria were developed for the prevention and control of COVID-19 infection during hyperbaric oxygen therapy. A questionnaire was used to measure compliance in baseline and follow-up audits.Results:Differences between the baseline and follow-up audits were noted for criteria 6 and 7. Criterion 6 increased from 0% to 100% as the hyperbaric facility was equipped with certified ultraviolet-C radiation for air disinfection during the later period, but this equipment was not available in the initial period of the pandemic. Criterion 7 dropped from 100% in the baseline audit to 0% in the follow-up audit because of a significant increase in the operational burden of the treatment capacity of the facility, which made it impossible to comply with the recommended distancing between patients.Conclusions:Differences were found in preventive measures, disinfection procedures, work organization, and approach to care strategy. The project objectives were met and the implementation strategies proved effective. Larger sample sizes would need be needed to confirm the reproducibility of the results.
ER  -

HAJEK, Michal, Dittmar CHMELAR, Miroslav ROZLOZNIK, Alexandra LOCHMANOVA, Jakub TLAPAK, Tereza VRBOVÁ, Miloslav KLUGAR a Jitka KLUGAROVÁ. COVID-19 infection prevention and control management during hyperbaric oxygen therapy: a best practice implementation project. \textit{JBI EVIDENCE IMPLEMENTATION}. PHILADELPHIA: LIPPINCOTT WILLIAMS \&{} WILKINS, 2023, roč.~21, S1, s.~''S57''-''S63'', 7 s. ISSN~2691-3321. Dostupné z: https://dx.doi.org/10.1097/XEB.0000000000000400.

Podrobný výpis o publikaci